Patents by Inventor Joseph Konopelski

Joseph Konopelski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B-LACTAM COMPOUNDS
    Publication number: 20170114014
    Abstract: Novel methods for the production of enantiomerically pure (EP) ?-lactams by decomposition of ?-diazo-?-ketoamides.
    Type: Application
    Filed: September 23, 2016
    Publication date: April 27, 2017
    Applicant: The Regents of the University of California
    Inventors: Joseph Konopelski, Maximillian Mahoney, Yvette S. Mimieux
  • METHOTREXATE ADJUVANTS TO REDUCE TOXICITY AND METHODS FOR USING THE SAME
    Publication number: 20090325969
    Abstract: Methods are provided for using methotrexate (MTX) active agents in which reduced host toxicity is observed. Aspects of the methods include administering to a subject an effective amount of an MTX active agent in conjunction with a MTX toxicity-reducing adjuvant, such as a 2,2?-anhydropyrimidine, a derivative thereof or a uridine phosphorylase inhibitor. Also provided are compositions and kits that find use in practicing embodiments of the invention. The methods and compositions find use in a variety of applications, including the treatment of a variety of different disease conditions.
    Type: Application
    Filed: March 2, 2009
    Publication date: December 31, 2009
    Inventors: William A. Garland, Brian D. Frenzel, Travis Karg, Todd Wipke, Joseph Konopelski